Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Dose Response Study of Patients With Erythematous Rosacea

ClinicalTrials.gov ID: NCT01186068

Public ClinicalTrials.gov record NCT01186068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of the Dose-Response Profile of V-101 Cream in Subjects With Erythematous Rosacea

Study identification

NCT ID
NCT01186068
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vicept Therapeutics, Inc.
Industry
Enrollment
175 participants

Conditions and interventions

Interventions

  • V-101 Drug
  • vehicle Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2010
Primary completion
Not listed
Completion
Not listed
Last update posted
Nov 23, 2010

Started 2010

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Therapeutics Clinical Research San Diego California 92123
Baumann Cosmetic & Research Institute Miami Beach Florida 33140
Dermatology Specialists Research Louisville Kentucky 40202
DBA Michigan Center for Skin Care Research Clinton Twp Michigan 48038
Academic Dermatology Associates Albuquerque New Mexico 87106
Oregon Medical Research Center, PC Portland Oregon 97223
DermResearch, Inc. Austin Texas 78759

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01186068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 23, 2010 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01186068 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →